Needham Reiterates Buy on Boston Scientific, Maintains $77 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.1%

Neg 0% Neu 87.1% Pos 0%

Needham analyst Mike Matson reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains $77 price target.

Comments

No comments yet. Be the first!